Source: Journal of Gastrointestinal Surgery. Unidade: FM
Subjects: MODELOS ANIMAIS, DOENÇAS GENÉTICAS, HAMSTERS, NEOPLASIAS PANCREÁTICAS, ADENOCARCINOMA
ABNT
MORIOKA, Cíntia Yoko et al. Are antisense oligonucleotides targeted K-ras point mutation effective in the treatment of hamster pancreatic cancer model?. Journal of Gastrointestinal Surgery, v. 9, n. 4, p. 530, 2005Tradução . . Disponível em: https://doi.org/10.1016/j.gassur.2005.01.027. Acesso em: 13 jul. 2024.APA
Morioka, C. Y., Matheus, A. S., Machado, M. C. C., Saito, S., Arai, H., Jukemura, J., et al. (2005). Are antisense oligonucleotides targeted K-ras point mutation effective in the treatment of hamster pancreatic cancer model? Journal of Gastrointestinal Surgery, 9( 4), 530. doi:10.1016/j.gassur.2005.01.027NLM
Morioka CY, Matheus AS, Machado MCC, Saito S, Arai H, Jukemura J, Sakamoto T, Bacchella T, Watanabe A. Are antisense oligonucleotides targeted K-ras point mutation effective in the treatment of hamster pancreatic cancer model? [Internet]. Journal of Gastrointestinal Surgery. 2005 ; 9( 4): 530.[citado 2024 jul. 13 ] Available from: https://doi.org/10.1016/j.gassur.2005.01.027Vancouver
Morioka CY, Matheus AS, Machado MCC, Saito S, Arai H, Jukemura J, Sakamoto T, Bacchella T, Watanabe A. Are antisense oligonucleotides targeted K-ras point mutation effective in the treatment of hamster pancreatic cancer model? [Internet]. Journal of Gastrointestinal Surgery. 2005 ; 9( 4): 530.[citado 2024 jul. 13 ] Available from: https://doi.org/10.1016/j.gassur.2005.01.027